2Selhub J,D' Angelo A.Relationship between homocysteine and thrombotic disease.Am J Med Sci,1998,316:129-141.
3Loffredo L,Violi F,Fimognari FL,et al.The association between hyperhomocysteinemia and ischemic stroke in patients with nonvalvular atrial fibrillation.Haematology,2005,90:1205-1211.
4Boysen G,Brander T,Christensen H,et al.Homocysteine and risk of recurrent stroke.Stroke,2003,34:1258-1261.
5Del Ser T,Barba R,Herranz AS,et al.Hyperhomocysteinemia is a risk factor of secondary vascular events in stroke patients.Cerebrovasc Dis,2001,12:91-98.
6Bos MJ,van Goor ML,Koudstaal PJ,et al.Plasma homocysteine is a risk factor for recurrent vascular events in young patients with an ischaemic stroke or TIA.J Neurol,2005,252:332-337.
7Duan J,Murohara J,Ikeda H,et al.Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia.Arterioscler Thromb Vasc Biol,2000,20:2579-2585.
8Demuth K,Atger V,Birderie D,et al.Homocysteine decreases endothelin-1 production by cultured human endothelial cells.Eur J Biochem,1999,263:367 -376.
9El Kossi MM,Zakhary MM.Oxidative stress in the context of acute cerebrovascular stroke.Stroke,2000,31:1889-1892.
10VITATOPS Trial Study Group.The VITATOPS (Vitamins to Prevent Stroke) Trial:rationale and design of an international,large,simple,randomized trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke.Cerebrovasc Dis,2002,13:120-126.
